Abstract
Hypothyroidism is characterized by deficient tissue thyroid hormone action overwhelmingly due to deficient endogenous thyroid hormone synthesis and secretion by the thyroid. Overt and subclinical hypothyroidism may or may not be associated with nonspecific symptoms that have become identified as consistent with the presence of hypothyroidism but are by no means specific to deficient thyroid hormone action. The diagnosis of hypothyroidism has evolved from a clinical impression based on symptoms (which some practitioners continue to deem sufficient) and now should also include biochemical evidence of thyroid dysfunction as indicated by contemporary guidelines for clinical practice. Once accurately diagnosed, hypothyroidism is expected to be readily treated by replacing thyroid hormone. The clinical management of hypothyroidism is assumed to be simple and direct. It is also assumed by some that symptoms persisting in patients diagnosed as hypothyroid are due to ongoing deficiency in thyroid hormone action on the impacted tissues of the body. But why would we assume that the initiation of thyroid hormone in subjects with symptoms “consistent with hypothyroidism” who are not hypothyroid should result in resolution of these non-thyroid complaints? This discussion examines potential pitfalls in diagnosis and how patients are selected for treatment with thyroid replacement and questions the safety and outcomes of thyroid hormone replacement therapy. Additionally, this review explores alternative explanations for symptoms that may result in the initial assessment of thyroid function tests and the diagnosis of hypothyroidism and offers an approach to persistent symptoms in those on thyroid hormone replacement presumed to be hypothyroid.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Canaris GJ, Steiner JF, Ridgway EC. Do traditional symptoms of hypothyroidism correlate with biochemical disease? J Gen Intern Med. 1997;12(9):544–50.
Canaris GJ, Manowitz NR, Mayor GH, Ridgway EC. The Colorado thyroid disease prevalence study. Arch Intern Med. 2000;160(4):526–34.
Garber JR, Cobin RH, Gharib H, Hennessey JV, Klein I, Mechanick JI, Pessah-Pollack R, Singer PA, Woeber KA. Clinical practice guidelines for hypothyroidism in adults: cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association. Thyroid. 2012;22(12):1200–35. https://doi.org/10.1089/thy.2012.0205.
Carle A, Pedersen IB, Knudsen N, Perrild H, Ovesen L, Andersen S, Laurberg P. Hypothyroid symptoms fail to predict thyroid insufficiency in old people: a population-based case-control study. Am J Med. 2016;129(10):1082–92. https://doi.org/10.1016/j.amjmed.2016.06.013.
Bould H, Panicker V, Kessler D, Durant C, Lewis G, Dayan C, Evans J. Investigation of thyroid dysfunction is more likely in patients with high psychological morbidity. Fam Pract. 2012;29(2):163–7. https://doi.org/10.1093/fampra/cmr059.
Saravanan P, Chau W-F, Roberts N, Vedhara K, Greenwood R, Dayan CM. Psychological well-being in patients on “adequate” doses of L-thyroxine: results of a large, controlled community-based questionaire study. Clin Endocrinol. 2002;57:577–85.
Pollock MA, Sturrock A, Marshall K, Davidson KM, Kelly CJG, McMahon AD, McLaren EH. Thyroxine treatment in patients with symptoms of hypothyroidism but thyroid function tests within the reference range: randomized double blind placebo controlled crossover trial. Br Med J. 2001;323(20 October):891–5.
Taylor PN, Iqbal A, Minassian C, Sayers A, Draman MS, Greenwood R, Hamilton W, Okosieme O, Panicker V, Thomas SL, Dayan C. Falling threshold for treatment of borderline elevated thyrotropin levels-balancing benefits and risks: evidence from a large community-based study. JAMA Intern Med. 2014;174(1):32–9. https://doi.org/10.1001/jamainternmed.2013.11312.
Stott DJ, Rodondi N, Kearney PM, Ford I, Westendorp RGJ, Mooijaart SP, Sattar N, Aubert CE, Aujesky D, Bauer DC, Baumgartner C, Blum MR, Browne JP, Byrne S, Collet TH, Dekkers OM, den Elzen WPJ, Du Puy RS, Ellis G, Feller M, Floriani C, Hendry K, Hurley C, Jukema JW, Kean S, Kelly M, Krebs D, Langhorne P, McCarthy G, McCarthy V, McConnachie A, McDade M, Messow M, O'Flynn A, O’Riordan D, Poortvliet RKE, Quinn TJ, Russell A, Sinnott C, Smit JWA, Van Dorland HA, Walsh KA, Walsh EK, Watt T, Wilson R, Gussekloo J. Thyroid hormone therapy for older adults with subclinical hypothyroidism. N Engl J Med. 2017;376(26):2534–44. https://doi.org/10.1056/NEJMoa1603825.
Somwaru LL, Rariy CM, Arnold AM, Cappola AR. The natural history of subclinical hypothyroidism in the elderly: the cardiovascular health study. J Clin Endocrinol Metab. 2012;97(6):1962–9. https://doi.org/10.1210/jc.2011-3047.
Vanderpump MPJ, Tunbridge WMG, French JM, Appleton D, Bates D, Clark F, Grimley Evans J, Hasan DM, Rodgers H, Tunbridge F, Young ET. The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey. Clin Endocrinol. 1995;43:55–68.
Baloch Z, Carayon P, Conte-Devolx B, Demers LM, Feldt-Rasmussen U, Henry JF, LiVosli VA, Niccoli-Sire P, John R, Ruf J, Smyth PP, Spencer CA, Stockigt JR. Laboratory medicine practice guidelines. Laboratory support for the diagnosis and monitoring of thyroid disease. Thyroid. 2003;13(1):3–126. https://doi.org/10.1089/105072503321086962.
Hollowell JG, Staehling NW, Flanders WD, Hannon WH, Gunter EW, Spencer CA. Serum TSH, T4, and thyroid antibodies in the United States population(1988 to 1994): National Health and Nutrition Survey (NHANES III). J Clin Endocrinol Metab. 2002;87:489–99.
Surks MI, Hollowell JG. Age-specific distribution of serum thyrotropin and antithyroid antibodies in the US population: implications for the prevalence of subclinical hypothyroidism. J Clin Endocrinol Metab. 2007). doi:jc.2007-1499 [pii];92(12):4575–82. https://doi.org/10.1210/jc.2007-1499.
Ehrenkranz J, Bach PR, Snow GL, Schneider A, Lee JL, Ilstrup S, Bennett ST, Benvenga S. Circadian and circannual rhythms in thyroid hormones: determining the TSH and free T4 reference intervals based upon time of day, age, and sex. Thyroid. 2015;25(8):954–61. https://doi.org/10.1089/thy.2014.0589.
Bremner AP, Feddema P, Leedman PJ, Brown SJ, Beilby JP, Lim EM, Wilson SG, O’Leary PC, Walsh JP. Age-related changes in thyroid function: a longitudinal study of a community-based cohort. J Clin Endocrinol Metab. 2012;97(5):1554–62. https://doi.org/10.1210/jc.2011-3020.
Fontes R, Coeli CR, Aguiar F, Vaisman M. Reference interval of thyroid stimulating hormone and free thyroxine in a reference population over 60 years old and in very old subjects (over 80 years): comparison to young subjects. Thyroid Res. 2013;6(1):13. https://doi.org/10.1186/1756-6614-6-13. 1756-6614-6-13 [pii].
Waring AC, Arnold AM, Newman AB, Buzkova P, Hirsch C, Cappola AR. Longitudinal changes in thyroid function in the oldest old and survival: the cardiovascular health study all-stars study. J Clin Endocrinol Metab. 2012;97(11):3944–50. https://doi.org/10.1210/jc.2012-2481.
Konno N. Comparison between the thyrotropin response to thyrotropin-releasing hormone in summer and that in winter in normal subjects. Endocrinol Jpn. 1978;25(6):635–9.
Kim TH, Kim KW, Ahn HY, Choi HS, Won H, Choi Y, Cho SW, Moon JH, Yi KH, Park DJ, Park KS, Jang HC, Kim SY, Park YJ. Effect of seasonal changes on the transition between subclinical hypothyroid and euthyroid status. J Clin Endocrinol Metab. 2013;98(8):3420–9. https://doi.org/10.1210/jc.2013-1607. jc.2013-1607 [pii].
Konno N, Morikawa K. Seasonal variation of serum thyrotropin concentration and thyrotropin response to thyrotropin-releasing hormone in patients with primary hypothyroidism on constant replacement dosage of thyroxine. J Clin Endocrinol Metab. 1982;54(6):1118–24. https://doi.org/10.1210/jcem-54-6-1118.
Gullo D, Latina A, Frasca F, Squatrito S, Belfiore A, Vigneri R. Seasonal variations in TSH serum levels in athyreotic patients under L-thyroxine replacement monotherapy. Clin Endocrinol. 2017;87(2):207–15. https://doi.org/10.1111/cen.13351.
Catli G, Anik A, Unver Tuhan H, Bober E, Abaci A. The effect of L-thyroxine treatment on hypothyroid symptom scores and lipid profile in children with subclinical hypothyroidism. J Clin Res Pediatr Endocrinol. 2014;6(4):238–44. https://doi.org/10.4274/Jcrpe.1594.
Stott DJ, Rodondi N, Bauer DC. Thyroid hormone therapy for older adults with subclinical hypothyroidism. N Engl J Med. 2017;377(14):e20. https://doi.org/10.1056/NEJMc1709989.
Massolt ET, van der Windt M, Korevaar TI, Kam BL, Burger JW, Franssen GJ, Lehmphul I, Kohrle J, Visser WE, Peeters RP. Thyroid hormone and its metabolites in relation to quality of life in patients treated for differentiated thyroid Cancer. Clin Endocrinol. 2016;85:781. https://doi.org/10.1111/cen.13101.
Hedman C, Djarv T, Strang P, Lundgren CI. Effect of thyroid-related symptoms on long-term quality of life in patients with differentiated thyroid carcinoma: a population-based study in Sweden. Thyroid. 2017;27(8):1034–42. https://doi.org/10.1089/thy.2016.0604.
Alhashemi A, Jones JM, Goldstein DP, Mina DS, Thabane L, Sabiston CM, Chang EK, Brierley JD, Sawka AM. An exploratory study of fatigue and physical activity in Canadian thyroid cancer patients. Thyroid. 2017;27(9):1156–63. https://doi.org/10.1089/thy.2016.0541. 10.1089/thy.2016.0541 [pii]
Ladenson PW. Psychological wellbeing in patients. Clin Endocrinol. 2002;57(5):575–6. doi:1682 [pii]
Saravanan P, Visser TJ, Dayan CM. Psychological well-being correlates with free thyroxine but not free 3,5,3′-triiodothyronine levels in patients on thyroid hormone replacement. J Clin Endocrinol Metab. 2006;91(9):3389–93. jc.2006-0414 [pii] 10.1210/jc.2006-0414.
Nygaard B, Jensen EW, Kvetny J, Jarlov A, Faber J. Effect of combination therapy with thyroxine (T4) and 3,5,3′-triiodothyronine versus T4 monotherapy in patients with hypothyroidism, a double-blind, randomised cross-over study. Eur J Endocrinol. 2009;161(6):895–902. https://doi.org/10.1530/EJE-09-0542. EJE-09-0542 [pii].
Wiersinga WM, Duntas L, Fadeyev V, Nygaard B, Vanderpump MP. 2012 ETA guidelines: the use of L-T4 + L-T3 in the treatment of hypothyroidism. Eur Thyroid J. 2012;1(2):55–71. https://doi.org/10.1159/000339444. etj-0001-0055 [pii].
Medici BB, la Cour JL, Michaelsson LF, Faber JO, Nygaard B. Neither baseline nor changes in serum triiodothyronine during levothyroxine/Liothyronine combination therapy predict a positive response to this treatment modality in hypothyroid patients with persistent symptoms. Eur Thyroid J. 2017;6(2):89–93. https://doi.org/10.1159/000454878. etj-0006-0089 [pii].
Flynn RW, Bonellie SR, Jung RT, MacDonald TM, Morris AD, Leese GP. Serum thyroid-stimulating hormone concentration and morbidity from cardiovascular disease and fractures in patients on long-term thyroxine therapy. J Clin Endocrinol Metab. 2010;95(1):186–93. https://doi.org/10.1210/jc.2009-1625. jc.2009-1625 [pii].
Mammen JS, McGready J, Oxman R, Chia CW, Ladenson PW, Simonsick EM. Thyroid hormone therapy and risk of thyrotoxicosis in community-resident older adults: findings from the Baltimore longitudinal study of aging. Thyroid. 2015;25(9):979–86. https://doi.org/10.1089/thy.2015.0180.
Sawin CT, Geller A, Wolf PA, Belanger AJ, Baker E, Bacharach P, Wilson PWF, Benjamin EJ, D'Agostino RB. Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons. N Engl J Med. 1994;331:1249–52.
Cappola AR, Fried LP, Arnold AM, Danese MD, Kuller LH, Burke GL, Tracey RP, Ladenson PW. Thyroid status, cardiovascular risk, and mortality in older adults. JAMA. 2006;295(9):1033–41.
Bauer DC, Ettinger B, Nevitt MC, Stone KL. Group, S.o.O.F.R.: risk for fracture in women with low levels of thyroid-stimulating hormone. Ann Intern Med. 2001;134(7):561–8.
Blum MR, Bauer DC, Collet TH, Fink HA, Cappola AR, da Costa BR, Wirth CD, Peeters RP, Asvold BO, den Elzen WP, Luben RN, Imaizumi M, Bremner AP, Gogakos A, Eastell R, Kearney PM, Strotmeyer ES, Wallace ER, Hoff M, Ceresini G, Rivadeneira F, Uitterlinden AG, Stott DJ, Westendorp RG, Khaw KT, Langhammer A, Ferrucci L, Gussekloo J, Williams GR, Walsh JP, Juni P, Aujesky D, Rodondi N. Subclinical thyroid dysfunction and fracture risk: a meta-analysis. JAMA. 2015;313(20):2055–65. https://doi.org/10.1001/jama.2015.5161.
Okosieme O, Gilbert J, Abraham P, Boelaert K, Dayan C, Gurnell M, Leese G, McCabe C, Perros P, Smith V, Williams G, Vanderpump M. Management of primary hypothyroidism: statement by the British Thyroid Association Executive Committee. Clin Endocrinol. 2016;84(6):799–808. https://doi.org/10.1111/cen.12824.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Hennessey, J.V. (2019). Non-thyroidal Hypothyroidism. In: McDermott, M. (eds) Management of Patients with Pseudo-Endocrine Disorders. Springer, Cham. https://doi.org/10.1007/978-3-030-22720-3_20
Download citation
DOI: https://doi.org/10.1007/978-3-030-22720-3_20
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-22719-7
Online ISBN: 978-3-030-22720-3
eBook Packages: MedicineMedicine (R0)